Abstract: FR-PO1130
Predictors of Mortality in COVID-19 Patients Diagnosed with AKI: A Case-Control Study
Session Information
- COVID-19 - II
November 03, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Coronavirus (COVID-19)
- 000 Coronavirus (COVID-19)
Authors
- Aroca Martinez, Gustavo, Universidad Simon Bolivar Facultad de Ciencias de la Salud, Barranquilla, Atlántico, Colombia
- Russi Pulgar, Daniela, Universidad del Norte Division Ciencias de la Salud, Barranquilla, Atlántico, Colombia
- Velez, Maria De Los Ángeles, Universidad Simon Bolivar Facultad de Ciencias de la Salud, Barranquilla, Atlántico, Colombia
- Musso, Carlos Guido, Universidad Simon Bolivar Facultad de Ciencias de la Salud, Barranquilla, Atlántico, Colombia
- Dominguez-Vargas, Alex, Universidad del Norte Division Ciencias de la Salud, Barranquilla, Atlántico, Colombia
- Navarro-Lechuga, Edgar, Universidad del Norte Division Ciencias de la Salud, Barranquilla, Atlántico, Colombia
Background
COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a multi-systemic infection with various manifestations, including acute kidney injury (AKI). This study aimed to identify factors associated with mortality in COVID-19 patients diagnosed with AKI during hospitalization at Clínica de la Costa in Barranquilla, Colombia from 2020 to 2022.
Methods
A case-control study. COVID-19 patients with acute kidney injury (AKI) were enrolled. Cases included fatal outcomes, while controls survived. AKI was defined using The Kidney Disease: Improving Global Outcomes criteria. A range of independent variables, including sociodemographic characteristics, comorbidities, initial laboratory parameters, and clinical features, were examined. Inferential analysis was performed using Chi-square, t-test, and Mann-Whitney U tests (p < 0.05). Associations were further evaluated using logistic regression, and odds ratios (ORs) with 95% confidence intervals were calculated.
Results
The study sample included 159 cases (deceased) and 74 controls (survivors). The average age in the deceased group was 66 ± 14 years, significantly higher than the average age of 59 ± 17 years in the survivor group (p-value = 0.005). No statistically significant differences were observed in terms of gender (p-value = 0.278) and municipality of residence (p-value = 0.078) between the study groups. The final adjusted model revealed several significant risk factors for mortality, including admission to the intensive care unit (OR = 4.8; 95% CI 1.5-15.6), invasive mechanical ventilation (OR = 51.1; 95% CI 10.9-240.7), renal replacement therapy (OR = 11.7; 95% CI 1.1-123.0), and Acute Kidney Injury Network (AKIN) II classification (OR = 8.8; 95% CI 2.5-30.5).
Conclusion
It is crucial for healthcare providers to maintain heightened surveillance in Covid-19 patients with AKI who require ICU admission, IMV, and RRT, as these factors are associated with higher mortality rates.
Funding
- Clinical Revenue Support